Compound preparation for inhibiting fat absorption and preparation method thereof

By using a compound preparation of Eucommia ulmoide, hawthorn leaves, lotus leaves and chitosan, fat absorption is inhibited, and the problems of poor effect and toxic side effects of existing weight loss preparations are solved, and safe and effective weight loss effects are achieved. In rats, it is also a good choice. The weight gain caused by a high-fat diet was significantly reduced in the experiment.

CN118985907AInactive Publication Date: 2024-11-22CHINA AGRI UNIV
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411093730.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-09
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing weight loss functional preparations have poor weight loss effects and have toxic side effects, making it difficult to achieve safe, effective and long-term weight loss needs.

Method used

A composite preparation, including Eucommia ulmoide leaves, hawthorn leaves, lotus leaves and chitosan, is prepared by soaking and heating treatment, and is used to inhibit fat absorption. The specific ratios and steps include different proportions of raw materials by mass parts or percentages. , and finally chitosan is added to prepare a compound preparation and used for processed food to inhibit fat absorption.

Benefits of technology

This compound preparation has a good inhibitory effect on pancreatic lipase, delaying digestion and dietary fat absorption. Experiments show that the weight can be significantly reduced in rats and has few side effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118985907A_ABST
    Figure CN118985907A_ABST
Patent Text Reader

Abstract

The invention discloses a compound preparation for inhibiting fat absorption and a preparation method thereof, and belongs to the technical field of food processing. Extracting solutions of eucommia ulmoides leaves, hawthorn leaves, lotus leaves and tea leaves are mixed with chitosan, and experiments prove that the prepared compound preparation has an inhibiting effect on pancreatic lipase; in a long-term animal experiment, the addition of the compound preparation has influence on the wet weight of excrement and the TG content of the excrement of high-fat diet rats; when the compound preparation is used for preparing pancreatic lipase, the wet weight and the TG content of excrement are increased, and the increase amplitude of an HF-EH group and an HF-O group exceeds that of an HF-EL group, so that the prepared compound preparation can inhibit the activity of pancreatic lipase, thereby reducing the absorption of dietary fat; after the compound preparation prepared by the invention is used for intervening the rats for 12 weeks, the weight increase caused by high-fat diet can be reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of food processing, and in particular relates to a composite preparation for inhibiting fat absorption and a preparation method thereof. Background Art

[0002] As people's living standards continue to improve, the incidence of obesity has increased year by year, and this problem has become one of the most important public health issues worldwide. Obesity may cause a variety of problems such as high blood pressure, high blood lipids, fatty liver, etc., which will have a serious impact on one's health. There are currently many treatments for obesity, including surgical weight loss, dieting and drug weight loss. Although surgical weight loss is quick, it has disadvantages such as harming the body and not lasting; drug weight loss generally increases the body's metabolism and energy consumption by taking hormone drugs, which will stimulate the central nervous system, and improper medication will cause damage to the liver; dieting is to achieve the purpose of weight loss by not eating or eating a small amount of food. This method is not only difficult to achieve the purpose of weight loss, but also causes serious harm to the body.

[0003] Most of the existing weight loss preparations contain drugs. If they are not taken in unlimited quantities, they will have certain toxic and side effects, posing a potential threat to human health. Traditional Chinese medicine for weight loss is also known as natural medicine for weight loss. It is widely promoted because of its low toxic and side effects and natural health. Existing studies have shown that traditional Chinese medicine has low toxic and side effects in the treatment of obesity. By regulating the internal organs, it helps patients lose weight and improve their quality of life. It has gradually become a common treatment for obesity in clinical practice. Therefore, it is of great practical significance to seek a convenient, safe, effective and long-term use traditional Chinese medicine for weight loss. Summary of the invention

[0004] The technical problem to be solved by the present invention is to provide a composite preparation for inhibiting fat absorption and a preparation method thereof, so as to solve the technical problem that the existing composite preparations have poor weight loss effects.

[0005] To achieve the above purpose, the technical solution adopted by the present invention is: to provide a composite preparation for inhibiting fat absorption, the raw materials used include, by weight: 20-30 parts of eucommia leaves, 20-25 parts of hawthorn leaves, 15-25 parts of lotus leaves, 15-25 parts of tea leaves and 1-5 parts of chitosan.

[0006] On the basis of the above technical solution, the present invention can also be improved as follows:

[0007] Furthermore, the raw materials used include, by mass, 25 parts of eucommia leaves, 23 parts of hawthorn leaves, 20 parts of lotus leaves, 20 parts of tea leaves and 2 parts of chitosan.

[0008] Furthermore, the raw materials used include, by mass percentage, 20 parts of eucommia leaves, 25 parts of hawthorn leaves, 15 parts of lotus leaves, 25 parts of tea leaves and 5 parts of chitosan.

[0009] Furthermore, the raw materials used include, by mass percentage, 30 parts of eucommia leaves, 20 parts of hawthorn leaves, 25 parts of lotus leaves, 15 parts of tea leaves and 1 part of chitosan.

[0010] The main components of Eucommia leaves include a variety of nutrients and medicinal ingredients, including a variety of amino acids, vitamins, minerals, polysaccharides and a variety of biologically active ingredients, such as chlorogenic acid, lignin, etc. These ingredients have a variety of health and pharmacological effects on the human body, including anti-oxidation, anti-fatigue, and immunity enhancement. In addition, Eucommia leaves are also rich in flavonoids, which have antibacterial and anti-inflammatory effects.

[0011] The main components of hawthorn leaves include flavonoids, triterpenoids, fatty acids and trace elements. Among them, flavonoids are the main active ingredients of hawthorn leaves, which have multiple biological activities, such as anti-oxidation, anti-inflammatory, and anti-tumor. In addition, hawthorn leaves also contain a variety of beneficial nutrients, such as multiple vitamins, minerals and dietary fiber.

[0012] Lotus leaf contains a variety of ingredients, the main active ingredients include nuciferine, citric acid, oxalic acid, nuciferin, etc., in addition to starch, oil and other organic matter and calcium ions. Among them, nuciferine has the effect of promoting fat metabolism and has a certain weight loss effect.

[0013] Tea contains a variety of nutrients, such as tea polyphenols, caffeine, etc.

[0014] Chitosan is a natural polysaccharide mainly derived from the shells of crustaceans. Chitosan has a variety of biological activities, such as antibacterial, anti-inflammatory, and antioxidant.

[0015] The present invention also discloses a method for preparing the above-mentioned composite preparation for inhibiting fat absorption, comprising the following steps: weighing other raw materials except chitosan in proportion, then soaking them in water for 25-35 minutes, finally heating them to 90-110°C and boiling them for 30-50 minutes, adding chitosan after cooling to room temperature, mixing them evenly, and obtaining the composite preparation.

[0016] Furthermore, the mass ratio of other raw materials to water is 1:2-3.

[0017] Furthermore, the cooking temperature is 100° C. and the cooking time is 40 min.

[0018] The invention also discloses a food processing method for inhibiting fat absorption, comprising the following steps: soaking nuts in a composite preparation at a ratio of 70-120wt%, cooking at 90-110°C for 10-20min, and then drying at 200-300°C for 10-20min to obtain food for inhibiting fat absorption.

[0019] The beneficial effects of the present invention are:

[0020] (1) Enzyme activity experiments show that the composite preparation prepared by the present invention has a good inhibitory effect on pancreatic lipase, and a composite preparation with a concentration of 40% can achieve half inhibition.

[0021] (2) In long-term animal experiments, the addition of the composite preparation had an effect on the fecal wet weight and fecal TG content of rats fed a high-fat diet; the wet weight and fecal TG content increased, and the increase in the HF-EH and HF-O groups exceeded that of the HF-EL group, indicating that the composite preparation prepared by the present invention can inhibit the activity of pancreatic lipase, thereby delaying digestion and reducing dietary fat absorption.

[0022] (3) In long-term animal experiments, the addition of the composite preparation had an effect on the body weight of rats fed a high-fat diet. Compared with the HFD group, the body weight of rats in the HF-EH, HF-EL and HF-O groups decreased by 4.4%, 2.7% and 8.9%, respectively, indicating that the composite preparation prepared by the present invention can reduce the weight gain caused by a high-fat diet in rats after 12 weeks of intervention. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 is the inhibition rate of the compound preparation on pancreatic lipase;

[0024] Figure 2 is the inhibition rate of orlistat on pancreatic lipase;

[0025] Figure 3 Figure 2 shows the changes in body weight of rats during the feeding period. DETAILED DESCRIPTION

[0026] The specific embodiments of the present invention are described below to facilitate the understanding of the present invention by those skilled in the art. If the specific conditions are not specified in the examples, the methods are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturers are not specified in the reagents or instruments used, they are all conventional products that can be purchased commercially. However, it should be clear that the present invention is not limited to the scope of the specific embodiments. For those skilled in the art, as long as various changes are within the spirit and scope of the present invention defined and determined by the attached claims, these changes are obvious, and all inventions and creations using the concept of the present invention are protected.

[0027] Example 1

[0028] A composite preparation with weight loss effect comprises the following raw materials by weight: 25 parts of eucommia leaves, 23 parts of hawthorn leaves, 20 parts of lotus leaves, 20 parts of tea leaves and 2 parts of chitosan.

[0029] The preparation method of the above-mentioned composite preparation comprises the following steps: except chitosan, other raw materials are weighed in proportion, then soaked in water for 25 minutes, finally heated to 90°C and boiled for 50 minutes, and chitosan is added after cooling to room temperature, mixed, and composite preparation A is obtained.

[0030] Example 2

[0031] A composite preparation with weight loss effect comprises the following raw materials by mass percentage: 20 parts of eucommia leaves, 25 parts of hawthorn leaves, 15 parts of lotus leaves, 25 parts of tea leaves and 5 parts of chitosan.

[0032] The preparation method of the above-mentioned composite preparation comprises the following steps: except chitosan, other raw materials are weighed in proportion, then soaked in water for 35 minutes, finally heated to 110°C and boiled for 30 minutes, and chitosan is added after cooling to room temperature, mixed, and composite preparation B is obtained.

[0033] Example 3

[0034] A composite preparation with weight loss effect, the raw materials used include, by mass percentage, 30 parts of eucommia leaves, 20 parts of hawthorn leaves, 25 parts of lotus leaves, 15 parts of tea leaves and 1 part of chitosan.

[0035] The preparation method of the above-mentioned composite preparation comprises the following steps: except chitosan, other raw materials are weighed in proportion, then soaked in water for 30 minutes, finally heated to 100°C and boiled for 40 minutes, and chitosan is added after cooling to room temperature, mixed, and composite preparation C is obtained.

[0036] Comparative Example

[0037] The difference between this comparative example and Example 1 is that chitosan is omitted, and the remaining components and preparation method are the same as those in Example 1, to obtain composite preparation D.

[0038] Prepare reagents:

[0039] (1) Tris-HCl buffer: Weigh Tris powder and dissolve it in distilled water. Add hydrochloric acid to adjust the pH to prepare a 0.1 mol / L, pH=8.2 buffer for later use.

[0040] (2) Pancreatic lipase solution: Weigh the pancreatic lipase solution and dissolve it in Tris-HCl (0.1 mol / L, pH=8.2) buffer to prepare a 5 mg / mL pancreatic lipase solution. Centrifuge at 3000 g for 10 min and take the supernatant for use.

[0041] (3) pNPL substrate solution: Weigh p-nitrophenol ester (pNPL) and dissolve it in sodium acetate (0.41 mg / mL, pH = 5.0) containing 1% Triton X-100 to prepare a 0.8 mg / mL substrate solution. Heat it in a boiling water bath for 1 min to aid dissolution and use it after cooling.

[0042] The following experiment was carried out using the composite preparation prepared in Example 1 as an example.

[0043] Experimental Example 1 In vitro inhibition of lipase activity

[0044] 0.2 mL of pancreatic lipase solution, 0.2 mL of the composite preparation and 0.5 mL of Tris-HCl buffer were mixed, and then preheated in a dry bath at 37°C for 10 minutes. Then, 0.6 mL of pNPL substrate solution was added to react for 20 minutes, and then the mixture was taken out and the reaction was terminated in a boiling water bath for 10 minutes. The sample solution was taken out and centrifuged at 3000 g for 5 minutes, and the supernatant was retained. The ultraviolet spectrophotometer was set to 405 nm, and its absorbance value was detected and the inhibition rate of the composite preparation on pancreatic lipase was calculated.

[0045] The reagents used in the experimental group were pancreatic lipase solution, compound preparation, Tris-HCl buffer and pNPL substrate solution; the reagents used in the experimental blank group were compound preparation, Tris-HCl buffer and pNPL substrate solution; the reagents used in the control group were pancreatic lipase solution, Tris-HCl buffer and pNPL substrate solution; the reagents used in the control blank group were Tris-HCl buffer and pNPL substrate solution; orlistat was used as a positive control.

[0046] The inhibition rate was calculated as follows:

[0047]

[0048] Among them, A 实验组 is the absorbance of the experimental group sample solution, A 实验空白组 is the absorbance of the blank sample solution, A 对照组 is the absorbance of the control group sample, A 对照空白组 is the absorbance of the blank sample solution.

[0049] In vitro activity is expressed as the concentration of the compound preparation. The compound preparation stock solution can inhibit pancreatic lipase activity by 50%, IC 50 The value is 40%, and the result is Figure 1 As shown in Figure 2, the concentration of the co-formulation was positively correlated with enzyme inhibition in a dose-dependent manner. With the increase of the concentration of the co-formulation and orlistat ( Figure 2 ), the activity of pancreatic lipase gradually decreases.

[0050] Experimental Example 2 Effects of the compound preparation on rats

[0051] 1. Establishment of long-term animal experiments

[0052] To evaluate the effect of the compound preparation on long-term fat accumulation in rat tissues, a long-term (12 weeks) animal study was conducted. SD rats were randomly divided into 8 groups: normal diet group (NCD), high-fat diet group (HFD), high-fat diet + 150 mL / kg compound preparation A group (HF-EL), high-fat diet + 300 mL / kg compound preparation A group (HF-EH), high-fat diet + 10 mg / kg orlistat group (HF-O), high-fat diet + 300 mL / kg compound preparation D group (HF-ED), nut control group (CH) and nut + compound preparation A group (CH-E), with 12 rats in each group. The ingredients of the rat diets in the normal diet group (NCD), high-fat diet group (HFD) and nut product group (CH / CH-E) are shown in Table 1.

[0053] Table 1 Composition of rat diets in the normal diet group (NCD), high-fat diet group (HFD) and nut product group (CH / CH-E)

[0054]

[0055] To avoid auto-oxidation of the fat component of the diet, food was freshly prepared weekly and stored at −20° C. The total amount of food consumed by the rats was recorded daily, and the rats were weighed once a week.

[0056] Three days before the end of the experiment, fresh feces samples within 12 hours were collected from rats, and the wet weight of the feces was recorded. Then, lipids in the feces were extracted with a chloroform:methanol (2:1, v / v) solution, followed by centrifugation at 3000g for 10 min to obtain the supernatant, which was then dried with nitrogen and mixed with 10wt% Triton X-100. The TG content in the feces was determined using a commercial triglyceride kit.

[0057] 2. Effect on fecal fat content

[0058] The results of TG content in feces of each group are shown in Table 2.

[0059] Table 2 TG content in feces of rats in each group

[0060] Group Name TG content in rat feces (mg / g) NCD 9.5+0.9 HFD 16.1+1.2 HF-EH 25.8+1.8 HF-EL 19.1+1.0 HF-O 30.3+2.3 HF-ED 17.1+1.1 CH 12.2+1.3 CH-E 14.3+1.1

[0061] Compared with rats in the normal diet group, the TG content in the feces of HFD rats increased, and after supplementing with the compound preparation or orlistat, the TG content in the feces of rats was significantly higher than that of the HFD group. The HF-EH and HF-EL groups were also higher than the HFD group. The fecal TG content of the HF-ED group was slightly higher than that of the HFD group, and the difference was not significant. The above results show that after rats on a high-fat diet supplemented with compound preparations or orlistat, the activity of pancreatic lipase can be inhibited, thereby delaying digestion, reducing dietary fat absorption, and increasing TG content in feces. After changing the formula of the compound preparation, the reduction in dietary fat absorption was not significant.

[0062] The data of fecal TG content of rats in the CH and CH-E groups showed that the fat absorption rate of nuts cooked with the composite preparation decreased, and the fecal TG content of the CH-E group was higher than that of the CH group.

[0063] 3. Effects on rat body weight

[0064] like Figure 3 As shown, at the beginning of the first week, the weights of the 8 groups of rats were similar. As the number of feeding days increased, the weights of the rats in each group increased to varying degrees, and the weight gain rate of rats fed with a high-fat diet was much faster than that of rats fed with a normal diet. After 12 weeks of feeding, the weights of the HFD, HF-EH, HF-EL, and HF-O groups were all higher than those of the normal diet group (NCD). Compared with the HFD group, the weights of rats in the HF-EH, HF-EL, and HF-O groups decreased by 4.4%, 2.7%, and 8.9%, respectively, indicating that the compound preparation can reduce the weight gain caused by a high-fat diet after 12 weeks of intervention in rats.

[0065] The weight gain rate of rats in CH and CH-E groups was higher than that of rats fed with normal diet (NCD), but lower than that of rats fed with high-fat diet (HCD). The weight gain rate of rats in CH-E group cooked with the composite preparation was lower than that of the CH group.

Claims

1. A composite preparation for inhibiting fat absorption, characterized in that: The raw materials used include, by weight: 20-30 parts of eucommia leaves, 20-25 parts of hawthorn leaves, 15-25 parts of lotus leaves, 15-25 parts of tea leaves and 1-5 parts of chitosan.

2. The composite preparation for inhibiting fat absorption according to claim 1, characterized in that: The raw materials used include, by weight: 25 parts of eucommia leaves, 23 parts of hawthorn leaves, 20 parts of lotus leaves, 20 parts of tea leaves and 2 parts of chitosan.

3. The composite preparation for inhibiting fat absorption according to claim 1, characterized in that: The raw materials used include, by weight percentage, 20 parts of eucommia leaves, 25 parts of hawthorn leaves, 15 parts of lotus leaves, 25 parts of tea leaves and 5 parts of chitosan.

4. The composite preparation for inhibiting fat absorption according to claim 1, characterized in that: The raw materials used include, by mass percentage, 30 parts of eucommia leaves, 20 parts of hawthorn leaves, 25 parts of lotus leaves, 15 parts of tea leaves and 1 part of chitosan.

5. The method for preparing the composite preparation for inhibiting fat absorption according to any one of claims 1 to 4, characterized in that: The following steps are involved: Except chitosan, other raw materials are weighed in proportion, then soaked in water for 25-35 minutes, finally heated to 90-110° C. and boiled for 30-50 minutes, and chitosan is added after cooling to room temperature, mixed, and a composite preparation is obtained.

6. The method for preparing the composite preparation for inhibiting fat absorption according to claim 5, characterized in that: The mass ratio of the other raw materials to water is 1:2-3.

7. The method for preparing the composite preparation for inhibiting fat absorption according to claim 5, characterized in that: The cooking temperature is 100° C. and the cooking time is 40 minutes.

8. A food processing method for inhibiting fat absorption, characterized in that: The method comprises the following steps: soaking nuts in a composite preparation according to any one of claims 1 to 4 at a ratio of 70-120 wt%, cooking at 90-110° C. for 10-20 min, and then drying at 200-300° C. for 10-20 min to obtain a food for inhibiting fat absorption.

Citation Information

Patent Citations

  • Tablet food and preparation process thereof

    CN101167578A

  • Composition with lipase inhibiting effect and application of same

    CN102511814A

  • Traditional Chinese medicine composition with functions of effectively reducing fat and losing weight as well as increasing immunity

    CN107184868A

  • Weight-reducing medicine, preparation method and application thereof

    CN107375847A

  • Tea extract for losing weight and preparation method thereof

    CN114601877A